Can we predict who will benefit from immunotherapy? new study aims to find out.
NCT ID NCT07147361
First seen Jun 27, 2026 · Last updated Jul 14, 2026 · Updated 2 times
Summary
This study is looking for biological markers (biomarkers) that might predict how well patients with certain types of squamous cell carcinoma respond to a type of immunotherapy called PD-1 inhibitors. Researchers will analyze blood and tumor tissue samples from 800 patients, both past and future, to develop a scoring system. The goal is to help doctors choose the right treatment for the right patient.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- PD-1 inhibitor (with or without chemotherapy)
- What this could lead to
- If successful, this could help doctors predict which patients with squamous cell carcinoma will benefit from PD-1 inhibitors, leading to more personalized treatment.
- What could go wrong
- This is an observational study, not a treatment trial. The biomarkers identified may not prove useful in practice, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Etiology and Carcinogenesis
Beijing, Beijing Municipality, 100021, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital peer support: a new weapon against cancer treatment anxiety?
- Can targeted radiation boost Immunotherapy's power against head and neck cancer?
- Can a new infusion drug shrink Hard-to-Treat tumors?
- Could a simple mouthwash protect cancer patients from Radiation's painful side effects?
- Can adding radiation boost the power of immunotherapy in advanced cervical cancer?
- Can a new drug combo shrink Hard-to-Treat tumors?